Hemorrhagic Stroke clinical trials

Explore recruiting hemorrhagic stroke clinical trials.

Recruiting hemorrhagic stroke studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hemorrhagic Stroke trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial

Germany, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Stroke prophylaxis with Apixaban in Chronic Kidney Disease stage 5 patients with Atrial fibrillation (SACK)

Sweden, Iceland, Finland, Norway, Netherlands, Poland +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress - The ASPIRE-AF trial

Denmark, Sweden, Spain, Netherlands, Italy, Finland +5 more

Therapeutic use (Phase IV) EU CTIS Study details

Low INR to Minimize bleeding with mechanical valves Trial (LIMIT)

Spain, Belgium, Denmark, Germany, Italy, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation

Spain, Austria, Czechia, Greece, Belgium, Italy +4 more

Therapeutic use (Phase IV) EU CTIS Study details

Anticoagulant Therapy in patients with atrial fibrillation after surgical Left Atrial Appendage Closure: a randomized non-inferiority trial (the ATLAAC trial)

Denmark, Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Hemorrhagic Stroke trials by city

Hemorrhagic Stroke in Toronto Hemorrhagic Stroke in Vancouver Hemorrhagic Stroke in Montreal Hemorrhagic Stroke in Calgary Hemorrhagic Stroke in Edmonton Hemorrhagic Stroke in Ottawa Hemorrhagic Stroke in Winnipeg Hemorrhagic Stroke in Quebec City Hemorrhagic Stroke in Hamilton Hemorrhagic Stroke in Kitchener Hemorrhagic Stroke in London Hemorrhagic Stroke in Halifax Hemorrhagic Stroke in New York Hemorrhagic Stroke in Los Angeles Hemorrhagic Stroke in Chicago Hemorrhagic Stroke in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease